The approximately 8.4% decrease in HCSM cell viability, observed under the 60–100 % v / v NHS conditions, did not reach statistical significance according to Tukey’s post-hoc test.
← all excerpts
CD59 Protects Primary Human Cerebrovascular Smooth Muscle Cells from Cytolytic Membrane Attack Complex.
1
—
—